Literature DB >> 21175677

Antibiotic heterogeneity: from concept to practice.

A M Bal1, A Kumar, I M Gould.   

Abstract

Bacterial resistance to multiple antibiotics is a serious and emerging threat. Several measures have been proposed to curb this growing trend. These include prescribing restrictions, education, and infection control that target transmission, among several others. Antibiotic cycling has been a subject of debate, and although many investigators have studied the utility of antibiotic cycling with the help of theoretical models or as part of clinical investigations, several areas remain undefined and unclear. This review summarizes the available information on antibiotic heterogeneity (antibiotic cycling, antibiotic mixing, and other types of antibiotic protocols) with a critical analysis of the published studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21175677     DOI: 10.1111/j.1749-6632.2010.05867.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  Bacterial recombination promotes the evolution of multi-drug-resistance in functionally diverse populations.

Authors:  Gabriel G Perron; Alexander E G Lee; Yun Wang; Wei E Huang; Timothy G Barraclough
Journal:  Proc Biol Sci       Date:  2011-11-02       Impact factor: 5.349

2.  Multidrug therapy and evolution of antibiotic resistance: when order matters.

Authors:  Gabriel G Perron; Sergey Kryazhimskiy; Daniel P Rice; Angus Buckling
Journal:  Appl Environ Microbiol       Date:  2012-06-22       Impact factor: 4.792

Review 3.  [Strategies to avoid antibiotic resistance].

Authors:  M G Kees
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-01-25       Impact factor: 0.840

4.  Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance.

Authors:  Seungsoo Kim; Tami D Lieberman; Roy Kishony
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

5.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Authors:  Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi
Journal:  Clin Infect Dis       Date:  2016-04-13       Impact factor: 9.079

6.  Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Authors:  K de With; F Allerberger; S Amann; P Apfalter; H-R Brodt; T Eckmanns; M Fellhauer; H K Geiss; O Janata; R Krause; S Lemmen; E Meyer; H Mittermayer; U Porsche; E Presterl; S Reuter; B Sinha; R Strauß; A Wechsler-Fördös; C Wenisch; W V Kern
Journal:  Infection       Date:  2016-06       Impact factor: 3.553

Review 7.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.

Authors:  Hiroshi Nikaido; Jean-Marie Pagès
Journal:  FEMS Microbiol Rev       Date:  2011-07-29       Impact factor: 16.408

8.  Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity?

Authors:  C Plüss-Suard; A Pannatier; A Kronenberg; K Mühlemann; G Zanetti
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

Review 9.  New antibiotic agents in the pipeline and how they can help overcome microbial resistance.

Authors:  Ian M Gould; Abhijit M Bal
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

10.  Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.

Authors:  Yong Chong; Shinji Shimoda; Hiroko Yakushiji; Yoshikiyo Ito; Toshihiro Miyamoto; Tomohiko Kamimura; Nobuyuki Shimono; Koichi Akashi
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.